Stay updated on Expanded Access Risdiplam in SMA Clinical Trial
Sign up to get notified when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.

Latest updates to the Expanded Access Risdiplam in SMA Clinical Trial page
- Check6 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded site revision note Revision: v3.4.2 and removed the funding/operating status notices; overall study content remains unchanged.SummaryDifference0.4%

- Check49 days agoChange DetectedAdded a site-wide notice informing users that, due to a lapse in government funding, information may not be up to date and transactions may not be processed. Also updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check56 days agoChange DetectedThe page now shows a glossary (Show glossary), includes a new revision indicator (v3.4.0), and contains minor capitalization tweaks in QC-related labels (e.g., 'Met QC Criteria' vs 'met QC Criteria' and 'Data' vs 'data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page adds Revision: v3.3.4 and removes Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Expanded Access Risdiplam in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.